Results 41 to 50 of about 1,399,337 (301)

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

open access: yesFEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová   +2 more
wiley   +1 more source

Advocating Global Road Safety

open access: yesJournal of Road Safety, 2007
The spate of youth road fatalities that we have seen in New South Wales in the last quarter of 2006 represents tragedies that no community should have to bear.
Lori Mooren
doaj  

Natural Products as Geroprotective Modulators in Diabetic Nephropathy: A Mechanistic Framework Integrating Aging Hallmarks and the AMPK–SIRT1–Nrf2 Axis

open access: yesAging and Cancer, EarlyView.
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu   +8 more
wiley   +1 more source

Road Safety for All

open access: yesJournal of Road Safety, 2016
My daughter, Zenani Zanethemba Mandela was tragically killed two days after celebrating her 13th birthday in a single vehicle drink-driving crash ahead of the 2010 FIFA World Cup in South Africa.
Zoleka Mandela
doaj  

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Occupational Road Safety 2020: Using PESTELED Analysis to Understand the Work-Related Road Safety Context

open access: yesJournal of Road Safety, 2011
Since the formation of the coalition government in the UK there has been increasing focus on, and debate about, cuts in the road safety budget. Such cuts will have many knock-on effects for road safety, including the work-related or fleet sector.
Will Murray
doaj  

Achieving safer school travel in the UK [PDF]

open access: yes, 2005
This paper summarises the current UK approach to improving child road safety, focusing particularly on measures to enhance the safety of the school journey.
Cairns, S.
core  

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Identification and Analysis of Problems in the Implementation of Road Safety Audit in Lithuania

open access: yesThe Baltic Journal of Road and Bridge Engineering, 2020
Road Safety Audits have already been tightly incorporated in the road design process throughout the world. It has proven to be an effective way of increasing road safety without requiring many resources.
Aja Tumavičė   +2 more
doaj   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy